FindTrial
Sign In

Evaluate FNAC of breast lesions using Yokohama classification and its correlation with BIRAD System

Categorisation of breast fine needle aspirates using Yokohama classification and its correlation with BIRAD system

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/04/051241
Enrollment
80
Registered
2023-04-03
Start date
Unknown
Completion date
Unknown
Last updated
2023-05-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: D249- Benign neoplasm of unspecified breast Health Condition 2: C509- Malignant neoplasm of breast of unspecified site Health Condition 3: N609- Unspecified benign mammary dysplasia Health Condition 4: N630- Unspecified lump in unspecified breast

Interventions

None listed

Sponsors

BPS GMC(W), Khanpur Kalan, Sonepat
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All the patients having breast lump whose both FNAC and BIRADS grading will be done

Exclusion criteria

Exclusion criteria: 1. Patients with ulcerative lesion or skin involvement. 2. Patients with history of chemotherapy and radiotherapy.

Design outcomes

Primary

MeasureTime frame
To evaluate FNAC of breast lesions using Yokohama classification and its correlation with the BIRAD system.Timepoint: 6 months, 1 year—

Secondary

MeasureTime frame
1. To categorise FNAC smears of breast lump according to Yokohama system. 2. To categorise the ultrasound findings of breast lump using USG based BIRAD system. 3. To find concordance between Yokohama system and USG based BIRAD system for reporting breast lesions. Timepoint: 6 months, 1 year—

Countries

India

Contacts

Public ContactDr Vishal

BPS GMC(W), Khanpur Kalan, Sonepat

kunduparveen2018@gmail.com9896211426

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026